Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Archives of Industrial Hygiene and Toxicology
Volume 73 (2022): Issue 1 (March 2022)
Open Access
Ochratoxin A potentiates citrinin accumulation in kidney and liver of rats
Dubravka Rašić
Dubravka Rašić
,
Srđan Stefanović
Srđan Stefanović
,
Dragan Milićević
Dragan Milićević
,
Marin Mladinić
Marin Mladinić
,
Davor Želježić
Davor Želježić
,
Alica Pizent
Alica Pizent
,
Paško Konjevoda
Paško Konjevoda
and
Maja Peraica
Maja Peraica
| Apr 07, 2022
Archives of Industrial Hygiene and Toxicology
Volume 73 (2022): Issue 1 (March 2022)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Original article
Published Online:
Apr 07, 2022
Page range:
43 - 47
Received:
Oct 01, 2021
Accepted:
Feb 01, 2022
DOI:
https://doi.org/10.2478/aiht-2022-73-3605
© 2022 Dubravka Rašić, Srđan Stefanović, Dragan Milićević, Marin Mladinić, Davor Želježić, Alica Pizent, Paško Konjevoda, Maja Peraica, published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Figure 1
Kidney ochratoxin A levels in rats treated with OTA doses of 125 μg/kg bw (OTA125) or 250 μg/kg bw (OTA250) alone or in combination with citrinin (CTN) and resveratrol (RSV), both in the dose of 20 mg/kg bw. a different from OTA125 alone; b different from OTA125+CTN; c different from OTA250 alone; d different from OTA250+CTN (P<0.05)
Figure 2
Liver ochratoxin A levels in rats treated with OTA doses of 125 μg/kg bw (OTA125) or 250 μg/kg bw (OTA250) alone or in combination with citrinin (CTN) and resveratrol (RSV), both in the dose of 20 mg/kg bw. a different from OTA125 alone; b different from OTA125+CTN; c different from OTA250 alone (P<0.05)
Figure 3
Kidney citrinin levels in rats treated with OTA doses of 125 μg/kg bw (OTA125) or 250 μg/ kg bw (OTA250) alone or in combination with citrinin (CTN) and resveratrol (RSV), both in the dose of 20 mg/kg bw. a different from CTN alone; b different from OTA250+CTN (P<0.05)
Figure 4
Liver citrinin levels in rats treated with OTA doses of 125 μg/kg bw (OTA125) or 250 μg/ kg bw (OTA250) alone or in combination with citrinin (CTN) and resveratrol (RSV), both in the dose of 20 mg/kg bw. a different from CTN alone (P<0.05)